Vraylar Using Patient and Healthcare Provider Hubs

Patient and Healthcare Provider Hub(1)

A healthcare data hub is an online platform based on the cloud, designed to facilitate the seamless access and sharing of patient-specific information among patients, providers, and payers. Patients can take a more prominent role in owning their health with the hub's creation. Medical records were historically kept solely by the provider, with little opportunity for the patient’s viewing. Hubs have allowed patients to see their notes from visits and communicate with their providers. Patients can add, update, and share data with their healthcare providers and facilities before appointments informing them of any physiological and domestic changes. This enables healthcare providers to have a comprehensive understanding of patient's medical history and current health status, empowering them to make informed recommendations and enhance patient outcomes. In addition, hubs offer better security for disparate data across health systems to reduce administrative workloads, thus lowering patient healthcare costs.

Patient and healthcare provider hubs store patient information securely, and protected health information laws are followed. In addition, healthcare data hubs provide artificial intelligence (AI)-enabled analytics to predict disease outbreaks, aid in quick and accurate diagnosis, and reduce treatment errors, providing the patient and provider with a better experience. Insurance payers also benefit as they can view and verify provider visits, labs, prescriptions, and procedures

Cariprazine/VraylarⓇ (2,3,4,)

Cariprazine is an atypical antipsychotic medication indicated for the treatment of schizophrenia and the acute treatment of manic or mixed episodes associated with bipolar 1 disorder. The exact mechanism of action in the treatment of schizophrenia and bipolar 1 disorder is unknown. However, it is believed to display partial agonist activity on central dopamine D2 receptors and serotonin 5HT1A receptors, while also acting as an antagonist on serotonin 5HT2A receptors. According to a report by the National Alliance on Mental Illness (NAMI), it is estimated that one in five individuals live with a mental condition. Since acquiring Allergen, AbbVie seeks to increase delivery of its non-specialty drug, Cariprazine. This can be done through the use of healthcare data hubs. The healthcare data hub company, Eversana, conducts real-time eligibility determination, initiates prior authorizations electronically to expedite the process, and streamlines co-pay eligibility and e-prescribing workflow, among other capabilities. Providers would be more apt to recommend and prescribe cariprazine to their patients if the workflow was streamlined and required less time. Other healthcare data hub companies, such as ConnectRx, offer easy access to product samples, patient savings, and drug-related and clinical resources. With the help of such a platform, healthcare providers can conveniently access Vraylar samples for distribution to patients, as well as access additional resources to enhance patient education about the medication.

Sources

1. Benefits. Healthcare Data Hubs. 2023

2. Mental Health. NAMI. 2023

3. Eversana. Access & Hub. 2023

4. Our Solutions. ConnectRx. 2023